THERAZONE ApS: Financial statements 2026
CVR: 27255574
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -476,020 and a net result of DKK 9,194,409. Equity in the 2026 report amounted to DKK 50,251,362. The solvency ratio was 95.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -476,020
- Profit/Loss
- DKK 9,194,409
- Equity
- DKK 50,251,362
- Total Assets
- DKK 52,530,703
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | -476K | 9.2M | 50.3M | 2 |
| 2024 | - | -256K | 4M | 44.8M | 2 |
| 2023 | - | -199K | 2.5M | 44.8M | 2 |
| 2022 | - | -83K | -2.2M | 42.5M | 2 |
| 2021 | - | -102K | 1.4M | 44.8M | 1 |
Official annual report
Find more companies like THERAZONE ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -476,020 and a net result of DKK 9,194,409. Equity in the 2026 report amounted to DKK 50,251,362.